Bausch Health Companies Inc (BHC)
$23.15 0.04 (0.17%)
16:49 EDT BHC Stock Quote Delayed 15 Minutes
Previous Close $23.19
Market Cap -
PE Ratio -8.77
Volume (Avg. Vol.) 2.45M
Day's Range 22.95 - 23.36
52-Week Range 17.20 - 28.45
Dividend & Yield N/A (N/A)
BHC Stock Predictions, Articles, and Bausch Health Companies Inc News
- From InvestorPlace
- From the Web
Eli Lilly, Alexion and AbbVie are just some of the top healthcare stocks to buy here, now that disappointing news has driven them to cheap prices.
After six straight sessions of losses, it was a welcomed sight to see stocks rally on Tuesday. Here's what happened on the stock market today.
Wall Street analysts see significant upside in these 10 stocks to buy. And all ten have other reasons for optimism as well.
Abbott is about to report another quarter to cap 2018's strong annual performance. ABT stock also offers a dividend for income investors.
Mylan stock jumped ahead following quarterly earnings that impressed investors. Management will continue doing better than expected.
Healthcare stocks recovered throughout 2018 but the recent correction in some big names is creating an entry point.
A company's own top management tend to have the best inside view into the business, so when company officers make major buys, investors are wise to take notice. Presumably the only reason an insider would take their hard-earned cash and use it to buy stock of their company in the open market, is that they expect to make money — maybe they find the stock very undervalued, or maybe they see exciting progress within the company, or maybe both..
From Seeking Alpha
Investors in Bausch Health Companies Inc (BHC) saw new options become available today, for the January 2022 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 858 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration..
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!